Tarsus COO Neervannan Seshadri sells 4,564 shares worth $387,940
Reuters2026/09/09 20:13- Chief Operating Officer Neervannan Seshadri sold 4,564 Tarsus Pharmaceuticals common shares on Sept. 4, 2026 at USD 85.
- Directly held stake fell to 78,532 shares following the sale.
- Form 4 also listed 475 shares held indirectly by his daughter.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Data: BTC has fallen below $78,000
Apple showcases its foldable screen iPhone; analysts see potential but warn of profit margin risks
Bloomberg Intelligence has raised its first-year sales estimate for the iPhone Duo to approximately 14 million units, with potential revenue reaching $28 billion. However, the pricing strategy has raised concerns in the market: the iPhone 17 and Air series will maintain their original prices, while the increase for the Pro series is lower than expected. Amid rising supply chain costs, this puts significant pressure on profit margins. Analysts believe that Apple aims to trade profit margin for sales volume and offset the pressure by driving an optimized mix of high-end models.
AutoNation CFO Tom Szlosek to speak at Morgan Stanley Laguna Conference fireside chat
Crypto prices
More
